Alternative end-joining pathway(s): Bricolage at DNA breaks

DNA Repair

Volumn 17, Issue , 2014, Pages 81-97

  Frit, Philippe ^a,b,c   Barboule, Nadia ^a,b,c   Yuan, Ying ^a,b,c   Gomez, Dennis ^a,b,c   Calsou, Patrick ^a,b,c  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Institute of Signalling Developmental Biology and Cancer Research   (France)

Author keywords

Class switch recombination; DNA double strand breaks (DSBs); DNA repair; Non homologous endjoining (NHEJ); Telomere; V(D)J Recombination

Indexed keywords

FLAP ENDONUCLEASE; GENOMIC DNA; HELICASE; POLYNUCLEOTIDE 5' HYDROXYL KINASE; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; DNA LIGASE; KU ANTIGEN;

ALTERNATIVE END JOINING; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME REARRANGEMENT; DNA END JOINING REPAIR; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; HOMEOSTASIS; HOMOLOGOUS RECOMBINATION; HUMAN; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NEOPLASM; PRIORITY JOURNAL; TELOMERE; BIOLOGICAL MODEL; DOUBLE STRANDED DNA BREAK; GENETICS; METABOLISM;

ANTIGENS, NUCLEAR; CHROMOSOMAL INSTABILITY; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA LIGASES; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; MODELS, GENETIC; NEOPLASMS;

EID: 84900439412     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.02.007     Document Type: Article

References (310)

1. Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 2001, 27:247-254.
2. Thompson L.H. Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat. Res. 2012, 751:158-246.
3. Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010, 79:181-211.
4. Szekvolgyi L., Nicolas A. From meiosis to postmeiotic events: homologous recombination is obligatory but flexible. Febs J. 2010, 277:571-589.
5. Schatz D.G., Swanson P.C. V(D)J recombination: mechanisms of initiation. Annu. Rev. Genet. 2011, 45:167-202.
6. Xu Z., Zan H., Pone E.J., Mai T., Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat. Rev. Immunol. 2012, 12:517-531.
7. Goodarzi A.A., Jeggo P.A. The repair and signaling responses to DNA double-strand breaks. Adv. Genet. 2013, 82:1-45.
8. Heyer W.D., Ehmsen K.T., Liu J. Regulation of homologous recombination in eukaryotes. Annu. Rev. Genet. 2010, 44:113-139.
9. Krejci L., Altmannova V., Spirek M., Zhao X. Homologous recombination and its regulation. Nucleic Acids Res. 2012, 40:5795-5818.
10. San Filippo J., Sung P., Klein H. Mechanism of eukaryotic homologous recombination. Annu. Rev. Biochem. 2008, 77:229-257.
11. Chiruvella K.K., Liang Z., Wilson T.E. Repair of double-strand breaks by end joining. Cold Spring Harb. Perspect. Biol. 2013, 5:a012757.
12. Wang C., Lees-Miller S.P. Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining. Int. J. Radiat. Oncol. Biol. Phys. 2013, 86:440-449.
13. Mahaney B.L., Meek K., Lees-Miller S.P. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem. J. 2009, 417:639-650.
14. Cottarel J., Frit P., Bombarde O., Salles B., Negrel A., Bernard S., Jeggo P.A., Lieber M.R., Modesti M., Calsou P. A noncatalytic function of the ligation complex during nonhomologous end joining. J. Cell Biol. 2013, 200:173-186.
15. Budman J., Kim S.A., Chu G. Processing of DNA for nonhomologous end-joining is controlled by kinase activity and XRCC4/ligase IV. J. Biol. Chem. 2007, 282:11950-11959.
16. Wang Y., Ghosh G., Hendrickson E.A. Ku86 represses lethal telomere deletion events in human somatic cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12430-12435.
17. Rampakakis E., Di Paola D., Zannis-Hadjopoulos M. Ku is involved in cell growth, DNA replication and G1-S transition. J. Cell Sci. 2008, 121:590-600.
18. Mo X., Dynan W.S. Subnuclear localization of Ku protein: functional association with RNA polymerase II elongation sites. Mol. Cell Biol. 2002, 22:8088-8099.
19. Cohen H.Y., Lavu S., Bitterman K.J., Hekking B., Imahiyerobo T.A., Miller C., Frye R., Ploegh H., Kessler B.M., Sinclair D.A. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol. Cell 2004, 13:627-638.
20. Chistiakov D.A., Voronova N.V., Chistiakov A.P. Ligase IV syndrome. Eur. J. Med. Genet. 2009, 52:373-378.
21. O'Driscoll M., Jeggo P.A. The role of double-strand break repair-insights from human genetics. Nat. Rev. Genet. 2006, 7:45-54.
22. Boulton S.J., Jackson S.P. Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double strand break rejoining and in telomeric maintenance. Nucleic Acids Res. 1996, 24:4639-4648.
23. Wilson T.E., Grawunder U., Lieber M.R. Yeast DNA ligase IV mediates non-homologous DNA end joining. Nature 1997, 388:495-498.
24. Aniukwu J., Glickman M.S., Shuman S. The pathways and outcomes of mycobacterial NHEJ depend on the structure of the broken DNA ends. Genes Dev. 2008, 22:512-527.
25. Heacock M., Spangler E., Riha K., Puizina J., Shippen D.E. Molecular analysis of telomere fusions in Arabidopsis: multiple pathways for chromosome end-joining. EMBO J. 2004, 23:2304-2313.
26. Pontier D.B., Tijsterman M. A robust network of double-strand break repair pathways governs genome integrity during C. elegans development. Curr. Biol. 2009, 19:1384-1388.
27. Gottlich B., Reichenberger S., Feldmann E., Pfeiffer P. Rejoining of DNA double-strand breaks in vitro by single-strand annealing. Eur. J. Biochem. 1998, 258:387-395.
28. Wang H., Zeng Z.C., Bui T.A., Sonoda E., Takata M., Takeda S., Iliakis G. Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group. Oncogene 2001, 20:2212-2224.
29. Chen S., Inamdar K.V., Pfeiffer P., Feldmann E., Hannah M.F., Yu Y., Lee J.W., Zhou T., Lees-Miller S.P., Povirk L.F. Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity. J. Biol. Chem. 2001, 276:24323-24330.
30. Feldmann E., Schmiemann V., Goedecke W., Reichenberger S., Pfeiffer P. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res. 2000, 28:2585-2596.
31. Kabotyanski E.B., Gomelsky L., Han J.O., Stamato T.D., Roth D.B. Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res. 1998, 26:5333-5342.
32. Verkaik N.S., Esveldt-van Lange R.E., van Heemst D., Bruggenwirth H.T., Hoeijmakers J.H., Zdzienicka M.Z., van Gent D.C. Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur. J. Immunol. 2002, 32:701-709.
33. Della-Maria J., Zhou Y., Tsai M.S., Kuhnlein J., Carney J., Paull T., Tomkinson A. hMre11/hRad50/Nbs1 and DNA ligase III{alpha}/XRCC1 act together in an alternative non-homologous end joining pathway. J. Biol. Chem. 2011, 286:33845-33853.
34. Wang H., Perrault A.R., Takeda Y., Qin W., Iliakis G. Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res. 2003, 31:5377-5388.
35. Bennardo N., Cheng A., Huang N., Stark J.M. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008, 4:e1000110.
36. Ma J.L., Kim E.M., Haber J.E., Lee S.E. Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair double-strand breaks lacking overlapping end sequences. Mol. Cell Biol. 2003, 23:8820-8828.
37. Decottignies A. Alternative end-joining mechanisms: a historical perspective. Front. Genet. 2013, 4:48.
38. Boboila C., Alt F.W., Schwer B. Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Adv. Immunol. 2012, 116:1-49.
39. Nick McElhinny S.A., Havener J.M., Garcia-Diaz M., Juarez R., Bebenek K., Kee B.L., Blanco L., Kunkel T.A., Ramsden D.A. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol. Cell 2005, 19:357-366.
40. Chan S.H., Yu A.M., McVey M. Dual roles for DNA polymerase theta in alternative end-joining repair of double-strand breaks in Drosophila. PLoS Genet. 2010, 6:e1001005.
41. Yu A.M., McVey M. Synthesis-dependent microhomology-mediated end joining accounts for multiple types of repair junctions. Nucleic Acids Res. 2010, 38:5706-5717.
42. Zhang Y., Gostissa M., Hildebrand D.G., Becker M.S., Boboila C., Chiarle R., Lewis S., Alt F.W. The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. Adv. Immunol. 2010, 106:93-133.
43. Pastwa E., Somiari R.I., Malinowski M., Somiari S.B., Winters T.A. In vitro non-homologous DNA end joining assays-the 20th anniversary. Int. J. Biochem. Cell Biol. 2009, 41:1254-1260.
44. Liang L., Deng L., Chen Y., Li G.C., Shao C., Tischfield J.A. Modulation of DNA end joining by nuclear proteins. J. Biol. Chem. 2005, 280:31442-31449.
45. Audebert M., Salles B., Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J. Biol. Chem. 2004, 279:55117-55126.
46. Perrault R., Wang H., Wang M., Rosidi B., Iliakis G. Backup pathways of NHEJ are suppressed by DNA-PK. J. Cell Biochem. 2004, 92:781-794.
47. Wang H., Rosidi B., Perrault R., Wang M., Zhang L., Windhofer F., Iliakis G. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res. 2005, 65:4020-4030.
48. Audebert M., Salles B., Weinfeld M., Calsou P. Involvement of polynucleotide kinase in a poly(ADP-ribose) polymerase-1-dependent DNA double-strand breaks rejoining pathway. J. Mol. Biol. 2006, 356:257-265.
49. Audebert M., Salles B., Calsou P. Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway. Biochem. Biophys. Res. Commun. 2008, 369:982-988.
50. Rosidi B., Wang M., Wu W., Sharma A., Wang H., Iliakis G. Histone H1 functions as a stimulatory factor in backup pathways of NHEJ. Nucleic Acids Res. 2008, 36:1610-1623.
51. Baumann P., West S.C. DNA end-joining catalyzed by human cell-free extracts. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14066-14070.
52. Lundberg R., Mavinakere M., Campbell C. Deficient DNA end joining activity in extracts from fanconi anemia fibroblasts. J. Biol. Chem. 2001, 276:9543-9549.
53. Hendrickson C.L., Purkayastha S., Pastwa E., Neumann R.D., Winters T.A. Coincident in vitro analysis of DNA-PK-dependent and -independent nonhomologous end joining. J. Nucleic Acids 2010, 2010:823917.
54. Gunn A., Stark J.M. I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks. Methods Mol. Biol. 2012, 920:379-391.
55. Magin S., Saha J., Wang M., Mladenova V., Coym N., Iliakis G. Lipofection and nucleofection of substrate plasmid can generate widely different readings of DNA end-joining efficiency in different cell lines. DNA Repair (Amst) 2012, 12:148-160.
56. Cheng Q., Barboule N., Frit P., Gomez D., Bombarde O., Couderc B., Ren G.S., Salles B., Calsou P. Ku counteracts mobilization of PARP1 and MRN in chromatin damaged with DNA double-strand breaks. Nucleic Acids Res. 2011, 39:9605-9619.
57. Hassa P.O., Haenni S.S., Elser M., Hottiger M.O. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?. Microbiol. Mol. Biol. Rev. 2006, 70:789-829.
58. De Vos M., Schreiber V., Dantzer F. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem. Pharmacol. 2012, 84:137-146.
59. Caldecott K.W. Single-strand break repair and genetic disease. Nat. Rev. Genet. 2008, 9:619-631.
60. Haince J.F., McDonald D., Rodrigue A., Dery U., Masson J.Y., Hendzel M.J., Poirier G.G. PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J. Biol. Chem. 2008, 283:1197-1208.
61. Wang M., Wu W., Wu W., Rosidi B., Zhang L., Wang H., Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 2006, 34:6170-6182.
62. Robert I., Dantzer F., Reina-San-Martin B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination,. J. Exp. Med. 2009, 206:1047-1056.
63. Sfeir A., de Lange T. Removal of shelterin reveals the telomere end-protection problem. Science 2012, 336:593-597.
64. Jia Q., Dulk-Ras A.D., Shen H., Hooykaas P.J., de Pater S. Poly(ADP-ribose)polymerases are involved in microhomology mediated back-up non-homologous end joining in Arabidopsis thaliana. Plant Mol. Biol. 2013, 82:339-351.
65. Ali A.A., Timinszky G., Arribas-Bosacoma R., Kozlowski M., Hassa P.O., Hassler M., Ladurner A.G., Pearl L.H., Oliver A.W. The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks. Nat. Struct. Mol. Biol. 2012, 19:685-692.
66. Williams R.S., Moncalian G., Williams J.S., Yamada Y., Limbo O., Shin D.S., Groocock L.M., Cahill D., Hitomi C., Guenther G., Moiani D., Carney J.P., Russell P., Tainer J.A. Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell 2008, 135:97-109.
67. Grabarz A., Barascu A., Guirouilh-Barbat J., Lopez B.S. Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining,. Am. J. Cancer Res. 2012, 2:249-268.
68. Huertas P. DNA resection in eukaryotes: deciding how to fix the break. Nat. Struct. Mol. Biol. 2010, 17:11-16.
69. Lee K., Lee S.E. Saccharomyces cerevisiae Sae2- and Tel1-dependent single-strand DNA formation at DNA break promotes microhomology-mediated end joining. Genetics 2007, 176:2003-2014.
70. Deriano L., Stracker T.H., Baker A., Petrini J.H., Roth D.B. Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. Mol. Cell 2009, 34:13-25.
71. Dinkelmann M., Spehalski E., Stoneham T., Buis J., Wu Y., Sekiguchi J.M., Ferguson D.O. Multiple functions of MRN in end-joining pathways during isotype class switching. Nat. Struct. Mol. Biol. 2009, 16:808-813.
72. Rass E., Grabarz A., Plo I., Gautier J., Bertrand P., Lopez B.S. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat. Struct. Mol. Biol. 2009, 16:819-824.
73. Xie A., Kwok A., Scully R. Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat. Struct. Mol. Biol. 2009, 16:814-818.
74. Kracker S., Bergmann Y., Demuth I., Frappart P.O., Hildebrand G., Christine R., Wang Z.Q., Sperling K., Digweed M., Radbruch A. Nibrin functions in Ig class-switch recombination. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1584-1589.
75. Zhuang J., Jiang G., Willers H., Xia F. The exonuclease function of human Mre11 promotes deletional non-homologous end-joining. J. Biol. Chem. 2009, 284:30565-30573.
76. Limbo O., Chahwan C., Yamada Y., de Bruin R.A., Wittenberg C., Russell P. Ctp1 is a cell-cycle-regulated protein that functions with Mre11 complex to control double-strand break repair by homologous recombination. Mol. Cell 2007, 28:134-146.
77. Sartori A.A., Lukas C., Coates J., Mistrik M., Fu S., Bartek J., Baer R., Lukas J., Jackson S.P. Human CtIP promotes DNA end resection. Nature 2007, 450:509-514.
78. Yun M.H., Hiom K. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature 2009, 459:460-463.
79. Helmink B.A., Sleckman B.P. The response to and repair of RAG-mediated DNA double-strand breaks. Annu. Rev. Immunol. 2012, 30:175-202.
80. Helmink B.A., Tubbs A.T., Dorsett Y., Bednarski J.J., Walker L.M., Feng Z., Sharma G.G., McKinnon P.J., Zhang J., Bassing C.H., Sleckman B.P. H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes. Nature 2011, 469:245-249.
81. Zhang Y., Jasin M. An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway. Nat. Struct. Mol. Biol. 2010, 18:80-84.
82. Lee-Theilen M., Matthews A.J., Kelly D., Zheng S., Chaudhuri J. CtIP promotes microhomology-mediated alternative end joining during class-switch recombination. Nat. Struct. Mol. Biol. 2011, 18:75-79.
83. Truong L.N., Li Y., Shi L.Z., Hwang P.Y., He J., Wang H., Razavian N., Berns M.W., Wu X. Microhomology-mediated end joining and homologous recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:7720-7725.
84. Rai R., Zheng H., He H., Luo Y., Multani A., Carpenter P.B., Chang S. The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J. 2010, 29:2598-2610.
85. Decottignies A. Microhomology-mediated end joining in fission yeast is repressed by pku70 and relies on genes involved in homologous recombination. Genetics 2007, 176:1403-1415.
86. Villarreal D.D., Lee K., Deem A., Shim E.Y., Malkova A., Lee S.E. Microhomology directs diverse DNA break repair pathways and chromosomal translocations. PLoS Genet. 2012, 8:e1003026.
87. Crespan E., Czabany T., Maga G., Hubscher U. Microhomology-mediated DNA strand annealing and elongation by human DNA polymerases lambda and beta on normal and repetitive DNA sequences. Nucleic Acids Res. 2012, 40:5577-5590.
88. Ahmad A., Robinson A.R., Duensing A., van Drunen E., Beverloo H.B., Weisberg D.B., Hasty P., Hoeijmakers J.H., Niedernhofer L.J. ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol. Cell Biol. 2008, 28:5082-5092.
89. Tseng H.M., Tomkinson A.E. Processing and joining of DNA ends coordinated by interactions among Dnl4/Lif1, Pol4, and FEN-1. J. Biol. Chem. 2004, 279:47580-47588.
90. Weinfeld M., Mani R.S., Abdou I., Aceytuno R.D., Glover J.N. Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repair. Trends Biochem. Sci. 2011, 36:262-271.
91. Liang L., Deng L., Nguyen S.C., Zhao X., Maulion C.D., Shao C., Tischfield J.A. Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks. Nucleic Acids Res. 2008, 36:3297-3310.
92. Cotner-Gohara E., Kim I.K., Hammel M., Tainer J.A., Tomkinson A.E., Ellenberger T. Human DNA ligase III recognizes DNA ends by dynamic switching between two DNA-bound states. Biochemistry 2010, 49:6165-6176.
93. Lakshmipathy U., Campbell C. The human DNA ligase III gene encodes nuclear and mitochondrial proteins. Mol. Cell Biol. 1999, 19:3869-3876.
94. Simsek D., Brunet E., Wong S.Y., Katyal S., Gao Y., McKinnon P.J., Lou J., Zhang L., Li J., Rebar E.J., Gregory P.D., Holmes M.C., Jasin M. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet. 2011, 7:e1002080.
95. Boboila C., Oksenych V., Gostissa M., Wang J.H., Zha S., Zhang Y., Chai H., Lee C.S., Jankovic M., Saez L.M., Nussenzweig M.C., McKinnon P.J., Alt F.W., Schwer B. Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1). Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2473-2478.
96. Windhofer F., Wu W., Iliakis G. Low levels of DNA ligases III and IV sufficient for effective NHEJ. J. Cell Physiol. 2007, 213:475-483.
97. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair (Amst) 2003, 2:955-969.
98. Charbonnel C., Gallego M.E., White C.I. Xrcc1-dependent and Ku-dependent DNA double-strand break repair kinetics in Arabidopsis plants. Plant J. 2010, 64:280-290.
99. Han L., Mao W., Yu K. X-ray repair cross-complementing protein 1 (XRCC1) deficiency enhances class switch recombination and is permissive for alternative end joining. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:4604-4608.
100. Saribasak H., Maul R.W., Cao Z., McClure R.L., Yang W., McNeill D.R., Wilson D.M., Gearhart 3rd P.J. XRCC1 suppresses somatic hypermutation and promotes alternative nonhomologous end joining in Igh genes. J. Exp. Med. 2011, 208:2209-2216.
101. Geuting V., Reul C., Lobrich M. ATM release at resected double-strand breaks provides heterochromatin reconstitution to facilitate homologous recombination. PLoS Genet. 2013, 9:e1003667.
102. Paul K., Wang M., Mladenov E., Bencsik-Theilen A., Bednar T., Wu W., Arakawa H., Iliakis G. DNA ligases I and III cooperate in alternative non-homologous end-joining in vertebrates. PLoS ONE 2013, 8:e59505.
103. Downs J.A., Jackson S.P. A means to a DNA end: the many roles of Ku. Nat. Rev. Mol. Cell Biol. 2004, 5:367-378.
104. Kun E., Kirsten E., Ordahl C.P. Coenzymatic activity of randomly broken or intact double-stranded DNAs in auto and histone H1 trans-poly(ADP-ribosylation), catalyzed by poly(ADP-ribose) polymerase (PARP I). J. Biol. Chem. 2002, 277:39066-39069.
105. D'Silva I., Pelletier J.D., Lagueux J., D'Amours D., Chaudhry M.A., Weinfeld M., Lees-Miller S.P., Poirier G.G. Relative affinities of poly(ADP-ribose) polymerase and DNA-dependent protein kinase for DNA strand interruptions. Biochim. Biophys. Acta 1999, 1430:119-126.
106. Ariumi Y., Masutani M., Copeland T.D., Mimori T., Sugimura T., Shimotohno K., Ueda K., Hatanaka M., Noda M. Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro. Oncogene 1999, 18:4616-4625.
107. Mansour W.Y., Schumacher S., Rosskopf R., Rhein T., Schmidt-Petersen F., Gatzemeier F., Haag F., Borgmann K., Willers H., Dahm-Daphi J. Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Res. 2008, 36:4088-4098.
108. Clerici M., Mantiero D., Guerini I., Lucchini G., Longhese M.P. The Yku70-Yku80 complex contributes to regulate double-strand break processing and checkpoint activation during the cell cycle. EMBO Rep. 2008, 9:810-818.
109. Fattah F., Lee E.H., Weisensel N., Wang Y., Lichter N., Hendrickson E.A. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet. 2010, 6:e1000855.
110. Guirouilh-Barbat J., Rass E., Plo I., Bertrand P., Lopez B.S. Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20902-20907.
111. Schulte-Uentrop L., El-Awady R.A., Schliecker L., Willers H., Dahm-Daphi J. Distinct roles of XRCC4 and Ku80 in non-homologous end-joining of endonuclease- and ionizing radiation-induced DNA double-strand breaks. Nucleic Acids Res. 2008, 36:2561-2569.
112. Mansour W.Y., Borgmann K., Petersen C., Dikomey E., Dahm-Daphi J. The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining. DNA Repair (Amst) 2013, 12:1134-1142.
113. Ochi T., Sibanda B.L., Wu Q., Chirgadze D.Y., Bolanos-Garcia V.M., Blundell T.L. Structural biology of DNA repair: spatial organisation of the multicomponent complexes of nonhomologous end joining. J. Nucleic Acids 2010, 621695.
114. Akopiants K., Zhou R.Z., Mohapatra S., Valerie K., Lees-Miller S.P., Lee K.J., Chen D.J., Revy P., de Villartay J.P., Povirk L.F. Requirement for XLF/Cernunnos in alignment-based gap filling by DNA polymerases {lambda} and {micro} for nonhomologous end joining in human whole-cell extracts. Nucleic Acids Res. 2009, 37:4055-4062.
115. Mladenov E., Iliakis G. Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways. Mutat. Res. 2011, 711:61-72.
116. Chapman J.R., Barral P., Vannier J.B., Borel V., Steger M., Tomas-Loba A., Sartori A.A., Adams I.R., Batista F.D., Boulton S.J. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 2013, 49:858-871.
117. Di Virgilio M., Callen E., Yamane A., Zhang W., Jankovic M., Gitlin A.D., Feldhahn N., Resch W., Oliveira T.Y., Chait B.T., Nussenzweig A., Casellas R., Robbiani D.F., Nussenzweig M.C. Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science 2013, 339:711-715.
118. Escribano-Diaz C., Orthwein A., Fradet-Turcotte A., Xing M., Young J.T., Tkac J., Cook M.A., Rosebrock A.P., Munro M., Canny M.D., Xu D., Durocher D. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol. Cell 2013, 49:872-883.
119. Feng L., Fong K.W., Wang J., Wang W., Chen J. RIF1 counteracts BRCA1-mediated end resection during DNA repair. J. Biol. Chem. 2013, 288:11135-11143.
120. Zimmermann M., Lottersberger F., Buonomo S.B., Sfeir A., de Lange T. 53BP1 regulates DSB repair using Rif1 to control 5' end resection. Science 2013, 339:700-704.
121. Bothmer A., Robbiani D.F., Feldhahn N., Gazumyan A., Nussenzweig A., Nussenzweig M.C. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J. Exp. Med. 2010, 207:855-865.
122. Wu W., Wang M., Singh S.K., Mussfeldt T., Iliakis G. Repair of radiation induced DNA double strand breaks by backup NHEJ is enhanced in G2. DNA Repair (Amst) 2008, 7:329-338.
123. Windhofer F., Wu W., Wang M., Singh S.K., Saha J., Rosidi B., Iliakis G. Marked dependence on growth state of backup pathways of NHEJ. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:1462-1470.
124. Singh S.K., Wu W., Zhang L., Klammer H., Wang M., Iliakis G. Widespread dependence of backup NHEJ on growth state: ramifications for the use of DNA-PK inhibitors. Int. J. Radiat. Oncol. Biol. Phys. 2010, 79:540-548.
125. Singh S.K., Bednar T., Zhang L., Wu W., Mladenov E., Iliakis G. Inhibition of B-NHEJ in plateau-phase cells is not a direct consequence of suppressed growth factor signaling. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84:e237-e243.
126. Alt F.W., Zhang Y., Meng F.L., Guo C., Schwer B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 2013, 152:417-429.
127. Desiderio S. Temporal and spatial regulatory functions of the V(D)J recombinase. Semin. Immunol. 2010, 22:362-369.
128. Ma Y., Pannicke U., Schwarz K., Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 2002, 108:781-794.
129. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., de Villartay J.P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001, 105:177-186.
130. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998, 95:891-902.
131. Li Z., Otevrel T., Gao Y., Cheng H.L., Seed B., Stamato T.D., Taccioli G.E., Alt F.W. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 1995, 83:1079-1089.
132. Taccioli G.E., Rathbun G., Oltz E., Stamato T., Jeggo P.A., Alt F.W. Impairment of V(D)J recombination in double-strand break repair mutants. Science 1993, 260:207-210.
133. Frank K.M., Sekiguchi J.M., Seidl K.J., Swat W., Rathbun G.A., Cheng H.L., Davidson L., Kangaloo L., Alt F.W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998, 396:173-177.
134. Nussenzweig A., Chen C., da Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 1996, 382:551-555.
135. Taccioli G.E., Gottlieb T.M., Blunt T., Priestley A., Demengeot J., Mizuta R., Lehmann A.R., Alt F.W., Jackson S.P., Jeggo P.A. Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 1994, 265:1442-1445.
136. Zhu C., Bogue M.A., Lim D.S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 1996, 86:379-389.
137. Gu Y., Jin S., Gao Y., Weaver D.T., Alt F.W. Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination,. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:8076-8081.
138. Ouyang H., Nussenzweig A., Kurimasa A., Soares V.C., Li X., Cordon-Cardo C., Li W., Cheong N., Nussenzweig M., Iliakis G., Chen D.J., Li G.C. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J. Exp. Med. 1997, 186:921-929.
139. Cui X., Meek K. Linking double-stranded DNA breaks to the recombination activating gene complex directs repair to the nonhomologous end-joining pathway. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17046-17051.
140. Corneo B., Wendland R.L., Deriano L., Cui X., Klein I.A., Wong S.Y., Arnal S., Holub A.J., Weller G.R., Pancake B.A., Shah S., Brandt V.L., Meek K., Roth D.B. Rag mutations reveal robust alternative end joining. Nature 2007, 449:483-486.
141. Lee G.S., Neiditch M.B., Salus S.S., Roth D.B. RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 2004, 117:171-184.
142. Talukder S.R., Dudley D.D., Alt F.W., Takahama Y., Akamatsu Y. Increased frequency of aberrant V(D)J recombination products in core RAG-expressing mice. Nucleic Acids Res. 2004, 32:4539-4549.
143. Deriano L., Chaumeil J., Coussens M., Multani A., Chou Y., Alekseyenko A.V., Chang S., Skok J.A., Roth D.B. The RAG2 C terminus suppresses genomic instability and lymphomagenesis. Nature 2011, 471:119-123.
144. Coussens M.A., Wendland R.L., Deriano L., Lindsay C.R., Arnal S.M., Roth D.B. RAG2's acidic hinge restricts repair-pathway choice and promotes genomic stability. Cell Rep. 2013, 4:870-878.
145. Katsura Y., Sasaki S., Sato M., Yamaoka K., Suzukawa K., Nagasawa T., Yokota J., Kohno T. Involvement of Ku80 in microhomology-mediated end joining for DNA double-strand breaks in vivo. DNA Repair (Amst) 2007, 6:639-648.
146. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 2008, 26:261-292.
147. Pan-Hammarström Q., Zhao Y., Hammarström L. Class switch recombination: a comparison between mouse and human. Adv. Immunol. 2007, 93:1-61.
148. Han L., Masani S., Yu K. Overlapping activation-induced cytidine deaminase hotspot motifs in Ig class-switch recombination. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11584-11589.
149. Boboila C., Yan C., Wesemann D.R., Jankovic M., Wang J.H., Manis J., Nussenzweig A., Nussenzweig M., Alt F.W. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J. Exp. Med. 2010, 207:417-427.
150. Han L., Yu K. Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV-deficient B cells. J. Exp. Med. 2008, 205:2745-2753.
151. Soulas-Sprauel P., Guyader G.L., Rivera-Munoz P., Abramowski V., Olivier-Martin C., Goujet-Zalc C., Charneau P., de Villartay J.P. Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination. J. Exp. Med. 2007, 204:1717-1727.
152. Yan C.T., Boboila C., Souza E.K., Franco S., Hickernell T.R., Murphy M., Gumaste S., Geyer M., Zarrin A.A., Manis J.P., Rajewsky K., Alt F.W. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007, 449:478-482.
153. Adams B.R., Hawkins A.J., Povirk L.F., Valerie K. ATM-independent high-fidelity nonhomologous end joining predominates in human embryonic stem cells. Aging (Albany NY) 2010, 2:582-596.
154. Callen E., Jankovic M., Wong N., Zha S., Chen H.T., Difilippantonio S., Di Virgilio M., Heidkamp G., Alt F.W., Nussenzweig A., Nussenzweig M. Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol. Cell 2009, 34:285-297.
155. Cook A.J., Oganesian L., Harumal P., Basten A., Brink R., Jolly C.J. Reduced switching in SCID B cells is associated with altered somatic mutation of recombined S regions. J. Immunol. 2003, 171:6556-6564.
156. Franco S., Murphy M.M., Li G., Borjeson T., Boboila C., Alt F.W. DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination. J. Exp. Med. 2008, 205:557-564.
157. Manis J.P., Dudley D., Kaylor L., Alt F.W. IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 2002, 16:607-617.
158. Rivera-Munoz P., Soulas-Sprauel P., Le Guyader G., Abramowski V., Bruneau S., Fischer A., Paques F., de Villartay J.P. Reduced immunoglobulin class switch recombination in the absence of Artemis. Blood 2009, 114:3601-3609.
159. Li G., Alt F.W., Cheng H.L., Brush J.W., Goff P.H., Murphy M.M., Franco S., Zhang Y., Zha S. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Mol. Cell 2008, 31:631-640.
160. Pan-Hammarström Q., Jones A.M., Lahdesmaki A., Zhou W., Gatti R.A., Hammarström L., Gennery A.R., Ehrenstein M.R. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J. Exp. Med. 2005, 201:189-194.
161. Du L., van der Burg M., Popov S.W., Kotnis A., van Dongen J.J., Gennery A.R., Pan-Hammarström Q. Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination. J. Exp. Med. 2008, 205:3031-3040.
162. Du L., Peng R., Bjorkman A., Filipe de Miranda N., Rosner C., Kotnis A., Berglund M., Liu C., Rosenquist R., Enblad G., Sundstrom C., Hojjat-Farsangi M., Rabbani H., Teixeira M.R., Revy P., Durandy A., Zeng Y., Gennery A.R., de Villartay J.P., Pan-Hammarstöm Q. Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis. J. Exp. Med. 2012, 209:291-305.
163. Boboila C., Jankovic M., Yan C.T., Wang J.H., Wesemann D.R., Zhang T., Fazeli A., Feldman L., Nussenzweig A., Nussenzweig M., Alt F.W. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3034-3039.
164. Lahdesmaki A., Taylor A.M., Chrzanowska K.H., Pan-Hammarström Q. Delineation of the role of the Mre11 complex in class switch recombination. J. Biol. Chem. 2004, 279:16479-16487.
165. Pan Q., Petit-Frere C., Lahdesmaki A., Gregorek H., Chrzanowska K.H., Hammarström L. Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur. J. Immunol. 2002, 32:1300-1308.
166. Reina-San-Martin B., Nussenzweig M.C., Nussenzweig A., Difilippantonio S. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1590-1595.
167. Lumsden J.M., McCarty T., Petiniot L.K., Shen R., Barlow C., Wynn T.A., Morse H.C., Gearhart 3rd P.J., Wynshaw-Boris A., Max E.E., Hodes R.J. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 2004, 200:1111-1121.
168. Pan-Hammarström Q., Dai S., Zhao Y., van Dijk-Hard I.F., Gatti R.A., Borresen-Dale A.L., Hammarström L. ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region. J. Immunol. 2003, 170:3707-3716.
169. Reina-San-Martin B., Chen H.T., Nussenzweig A., Nussenzweig M.C. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med. 2004, 200:1103-1110.
170. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., Redon C., Pilch D.R., Olaru A., Eckhaus M., Camerini-Otero R.D., Tessarollo L., Livak F., Manova K., Bonner W.M., Nussenzweig M.C., Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science 2002, 296:922-927.
171. Franco S., Gostissa M., Zha S., Lombard D.B., Murphy M.M., Zarrin A.A., Yan C., Tepsuporn S., Morales J.C., Adams M.M., Lou Z., Bassing C.H., Manis J.P., Chen J., Carpenter P.B., Alt F.W. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol. Cell 2006, 21:201-214.
172. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R., Redon C., Ried T., Bonner W.M., Honjo T., Nussenzweig M.C., Nussenzweig A. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 2001, 414:660-665.
173. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., Nussenzweig A., Nussenzweig M.C. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 2006, 440:105-109.
174. Reina-San-Martin B., Difilippantonio S., Hanitsch L., Masilamani R.F., Nussenzweig A., Nussenzweig M.C. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 2003, 197:1767-1778.
175. Lou Z., Minter-Dykhouse K., Franco S., Gostissa M., Rivera M.A., Celeste A., Manis J.P., van Deursen J., Nussenzweig A., Paull T.T., Alt F.W., Chen J. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell 2006, 21:187-200.
176. Li L., Halaby M.J., Hakem A., Cardoso R., El Ghamrasni S., Harding S., Chan N., Bristow R., Sanchez O., Durocher D., Hakem R. Rnf8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer. J. Exp. Med. 2010, 207:983-997.
177. Ramachandran S., Chahwan R., Nepal R.M., Frieder D., Panier S., Roa S., Zaheen A., Durocher D., Scharff M.D., Martin A. The RNF8/RNF168 ubiquitin ligase cascade facilitates class switch recombination. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:809-814.
178. Santos M.A., Huen M.S., Jankovic M., Chen H.T., Lopez-Contreras A.J., Klein I.A., Wong N., Barbancho J.L., Fernandez-Capetillo O., Nussenzweig M.C., Chen J., Nussenzweig A. Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J. Exp. Med. 2010, 207:973-981.
179. Bohgaki T., Bohgaki M., Cardoso R., Panier S., Zeegers D., Li L., Stewart G.S., Sanchez O., Hande M.P., Durocher D., Hakem A., Hakem R. Genomic instability, defective spermatogenesis, immunodeficiency, and cancer in a mouse model of the RIDDLE syndrome. PLoS Genet. 2011, 7:e1001381.
180. Bothmer A., Robbiani D.F., Di Virgilio M., Bunting S.F., Klein I.A., Feldhahn N., Barlow J., Chen H.T., Bosque D., Callen E., Nussenzweig A., Nussenzweig M.C. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol. Cell 2011, 42:319-329.
181. Manis J.P., Morales J.C., Xia Z., Kutok J.L., Alt F.W., Carpenter P.B. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat. Immunol. 2004, 5:481-487.
182. Reina-San-Martin B., Chen J., Nussenzweig A., Nussenzweig M.C. Enhanced intra-switch region recombination during immunoglobulin class switch recombination in 53BP1-/- B cells. Eur. J. Immunol. 2007, 37:235-239.
183. Ward I.M., Reina-San-Martin B., Olaru A., Minn K., Tamada K., Lau J.S., Cascalho M., Chen L., Nussenzweig A., Livak F., Nussenzweig M.C., Chen J. 53BP1 is required for class switch recombination. J. Cell Biol. 2004, 165:459-464.
184. Pan-Hammarström Q., Lahdesmaki A., Zhao Y., Du L., Zhao Z., Wen S., Ruiz-Perez V.L., Dunn-Walters D.K., Goodship J.A., Hammarström L. Disparate roles of ATR and ATM in immunoglobulin class switch recombination and somatic hypermutation. J. Exp. Med. 2006, 203:99-110.
185. Bothmer A., Rommel P.C., Gazumyan A., Polato F., Reczek C.R., Muellenbeck M.F., Schaetzlein S., Edelmann W., Chen P.L., Brosh R.M., Casellas R., Ludwig T., Baer R., Nussenzweig A., Nussenzweig M.C., Robbiani D.F. Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. J. Exp. Med. 2012, 210:115-123.
186. Palm W., de Lange T. How Shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008, 42:301-334.
187. Bombarde O., Boby C., Gomez D., Frit P., Giraud-Panis M.J., Gilson E., Salles B., Calsou P. TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric ends. EMBO J. 2010, 29:1573-1584.
188. Oh S., Wang Y., Zimbric J., Hendrickson E.A. Human LIGIV is synthetically lethal with the loss of Rad54B-dependent recombination and is required for certain chromosome fusion events induced by telomere dysfunction. Nucleic Acids Res. 2012, 41:1734-1749.
189. Karlseder J., Hoke K., Mirzoeva O.K., Bakkenist C., Kastan M.B., Petrini J.H., de Lange T. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2004, 2:E240.
190. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448:1068-1071.
191. Deng Y., Guo X., Ferguson D.O., Chang S. Multiple roles for MRE11 at uncapped telomeres. Nature 2009, 460:914-918.
192. Guo X., Deng Y., Lin Y., Cosme-Blanco W., Chan S., He H., Yuan G., Brown E.J., Chang S. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J. 2007, 26:4709-4719.
193. Bae N.S., Baumann P. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell 2007, 26:323-334.
194. Sarthy J., Bae N.S., Scrafford J., Baumann P. Human RAP1 inhibits non-homologous end joining at telomeres. EMBO J. 2009, 28:3390-3399.
195. Smogorzewska A., Karlseder J., Holtgreve-Grez H., Jauch A., de Lange T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 2002, 12:1635-1644.
196. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413.
197. Celli G.B., Denchi E.L., de Lange T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 2006, 8:885-890.
198. Manova V.I., Singh S.K., Iliakis G. Processing of DNA double strand breaks by alternative non-homologous end-joining in hyperacetylated chromatin. Genome Integr. 2012, 3:4.
199. Dimitrova N., Chen Y.C., Spector D.L., de Lange T. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature 2008, 456:524-528.
200. Lottersberger F., Bothmer A., Robbiani D.F., Nussenzweig M.C., de Lange T. Role of 53BP1 oligomerization in regulating double-strand break repair. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:2146-2151.
201. Xin H., Liu D., Wan M., Safari A., Kim H., Sun W., apos M.S., Connor O., Songyang Z. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007, 445:559-562.
202. Bailey S.M., Meyne J., Chen D.J., Kurimasa A., Li G.C., Lehnert B.E., Goodwin E.H. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14899-14904.
203. d'Adda di Fagagna F., Hande M.P., Tong W.M., Roth D., Lansdorp P.M., Wang Z.Q., Jackson S.P. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 2001, 11:1192-1196.
204. Espejel S., Klatt P., Menissier-de Murcia J., Martin-Caballero J., Flores J.M., Taccioli G., de Murcia G., Blasco M.A. Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs. J. Cell Biol. 2004, 167:627-638.
205. Hsu H.L., Gilley D., Galande S.A., Hande M.P., Allen B., Kim S.H., Li G.C., Campisi J., Kohwi-Shigematsu T., Chen D.J. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 2000, 14:2807-2812.
206. Li H., Vogel H., Holcomb V.B., Gu Y., Hasty P. Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer. Mol. Cell Biol. 2007, 27:8205-8214.
207. Samper E., Goytisolo F.A., Slijepcevic P., van Buul P.P., Blasco M.A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 2000, 1:244-252.
208. Gilley D., Tanaka H., Hande M.P., Kurimasa A., Li G.C., Oshimura M., Chen D.J. DNA-PKcs is critical for telomere capping. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15084-15088.
209. Goytisolo F.A., Samper E., Edmonson S., Taccioli G.E., Blasco M.A. The absence of the dna-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell Biol. 2001, 21:3642-3651.
210. Baumann P., Cech T.R. Protection of telomeres by the Ku protein in fission yeast. Mol. Biol. Cell 2000, 11:3265-3275.
211. Gravel S., Chapman J.R., Magill C., Jackson S.P. DNA helicases Sgs1 and BLM promote DNA double-strand break resection. Genes Dev. 2008, 22:2767-2772.
212. Kazda A., Zellinger B., Rössler M., Derboven E., Kusenda B., Riha K. Chromosome end protection by blunt-ended telomeres. Genes Dev. 2012, 26:1703-1713.
213. Polotnianka R.M., Li J., Lustig A.J. The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr. Biol. 1998, 8:831-834.
214. Riha K., Shippen D.E. Ku is required for telomeric C-rich strand maintenance but not for end-to-end chromosome fusions in Arabidopsis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:611-615.
215. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
216. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874.
217. Espejel S., Franco S., Rodriguez-Perales S., Bouffler S.D., Cigudosa J.C., Blasco M.A. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 2002, 21:2207-2219.
218. Maser R.S., Wong K.K., Sahin E., Xia H., Naylor M., Hedberg H.M., Artandi S.E., DePinho R.A. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol. Cell Biol. 2007, 27:2253-2265.
219. Wang X., Baumann P. Chromosome fusions following telomere loss are mediated by single-strand annealing. Mol. Cell 2008, 31:463-473.
220. Heacock M.L., Idol R.A., Friesner J.D., Britt A.B., Shippen D.E. Telomere dynamics and fusion of critically shortened telomeres in plants lacking DNA ligase IV. Nucleic Acids Res. 2007, 35:6490-6500.
221. Capper R., Britt-Compton B., Tankimanova M., Rowson J., Letsolo B., Man S., Haughton M., Baird D.M. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 2007, 21:2495-2508.
222. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
223. Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J. Cell Sci. 2008, 121(Suppl. 1):1-84.
224. Nowell P., Hungerford D. A minute chromosome in human granulocytic leukemia. Science 1960, 132:1497.
225. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
226. Shaffer D.R., Pandolfi P.P. Breaking the rules of cancer. Nat. Med. 2006, 12:14-15.
227. Gostissa M., Alt F.W., Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu. Rev. Immunol. 2011, 29:319-350.
228. Zhang Y., Rowley J.D. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst) 2006, 5:1282-1297.
229. Chiarle R. Translocations in normal B cells and cancers: insights from new technical approaches. Adv. Immunol. 2013, 117:39-71.
230. Betti C.J., Villalobos M.J., Jiang Q., Cline E., Diaz M.O., Loredo G., Vaughan A.T. Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity. Leukemia 2005, 19:2289-2295.
231. Stanulla M., Wang J., Chervinsky D.S., Thandla S., Aplan P.D. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol. Cell Biol. 1997, 17:4070-4079.
232. Britton S., Frit P., Biard D., Salles B., Calsou P. ARTEMIS nuclease facilitates apoptotic chromatin cleavage. Cancer Res. 2009, 69:8120-8126.
233. Cowell I.G., Austin C.A. Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents. Int. J. Environ. Res. Public Health 2012, 9:2075-2091.
234. Whitmarsh R.J., Saginario C., Zhuo Y., Hilgenfeld E., Rappaport E.F., Megonigal M.D., Carroll M., Liu M., Osheroff N., Cheung N.K., Slater D.J., Ried T., Knutsen T., Blair I.A., Felix C.A. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing. Oncogene 2003, 22:8448-8459.
235. Hochegger H., Dejsuphong D., Fukushima T., Morrison C., Sonoda E., Schreiber V., Zhao G.Y., Saberi A., Masutani M., Adachi N., Koyama H., de Murcia G., Takeda S. Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cells. EMBO J. 2006, 25:1305-1314.
236. Patel A.G., Sarkaria J.N., Kaufmann S.H. Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3401-3406.
237. Bryant H.E., Helleday T. Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents. Biochem. Soc. Trans. 2004, 32:959-961.
238. Farmer H., McCabe N., Lord C.J., Tutt A.N., Johnson D.A., Richardson T.B., Santarosa M., Dillon K.J., Hickson I., Knights C., Martin N.M., Jackson S.P., Smith G.C., Ashworth A. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005, 434:917-921.
239. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000, 404:510-514.
240. Ferguson D.O., Sekiguchi J.M., Chang S., Frank K.M., Gao Y., DePinho R.A., Alt F.W. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6630-6633.
241. Karanjawala Z.E., Grawunder U., Hsieh C.L., Lieber M.R. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 1999, 9:1501-1504.
242. Zha S., Alt F.W., Cheng H.L., Brush J.W., Li G. Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4518-4523.
243. Simsek D., Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat. Struct. Mol. Biol. 2010, 17:410-416.
244. Weinstock D.M., Brunet E., Jasin M. Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70. Nat. Cell Biol. 2007, 9:978-981.
245. Wray J., Williamson E.A., Singh S.B., Wu Y., Cogle C.R., Weinstock D.M., Zhang Y., Lee S.H., Zhou D., Shao L., Hauer-Jensen M., Pathak R., Klimek V., Nickoloff J.A., Hromas R. PARP1 is required for chromosomal translocations. Blood 2013, 121:4359-4365.
246. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., Lopez B.S. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol. Cell 2004, 14:611-623.
247. Lim D.S., Vogel H., Willerford D.M., Sands A.T., Platt K.A., Hasty P. Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol. Cell Biol. 2000, 20:3772-3780.
248. Difilippantonio M.J., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 2002, 196:469-480.
249. Bogue M.A., Zhu C., Aguilar-Cordova E., Donehower L.A., Roth D.B. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 1996, 10:553-565.
250. Guidos C.J., Williams C.J., Grandal I., Knowles G., Huang M.T., Danska J.S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 1996, 10:2038-2054.
251. Nacht M., Strasser A., Chan Y.R., Harris A.W., Schlissel M., Bronson R.T., Jacks T. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 1996, 10:2055-2066.
252. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 2000, 5:993-1002.
253. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 2000, 404:897-900.
254. Rooney S., Sekiguchi J., Whitlow S., Eckersdorff M., Manis J.P., Lee C., Ferguson D.O., Alt F.W. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2410-2415.
255. Liu X., Jiang W., Dubois R.L., Yamamoto K., Wolner Z., Zha S. Overlapping functions between XLF repair protein and 53BP1 DNA damage response factor in end joining and lymphocyte development. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:3903-3908.
256. Oksenych V., Alt F.W., Kumar V., Schwer B., Wesemann D.R., Hansen E., Patel H., Su A., Guo C. Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombination and DNA repair. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2455-2460.
257. Zha S., Jiang W., Fujiwara Y., Patel H., Goff P.H., Brush J.W., Dubois R.L., Alt F.W. Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2028-2033.
258. Gladdy R.A., Taylor M.D., Williams C.J., Grandal I., Karaskova J., Squire J.A., Rutka J.T., Guidos C.J., Danska J.S. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell 2003, 3:37-50.
259. Vanasse G.J., Halbrook J., Thomas S., Burgess A., Hoekstra M.F., Disteche C.M., Willerford D.M. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J. Clin. Invest. 1999, 103:1669-1675.
260. Zhu C., Mills K.D., Ferguson D.O., Lee C., Manis J., Fleming J., Gao Y., Morton C.C., Alt F.W. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002, 109:811-821.
261. Wang J.H., Alt F.W., Gostissa M., Datta A., Murphy M., Alimzhanov M.B., Coakley K.M., Rajewsky K., Manis J.P., Yan C.T. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. J. Exp. Med. 2008, 205:3079-3090.
262. Wang J.H., Gostissa M., Yan C.T., Goff P., Hickernell T., Hansen E., Difilippantonio S., Wesemann D.R., Zarrin A.A., Rajewsky K., Nussenzweig A., Alt F.W. Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 2009, 460:231-236.
263. Muller J.R., Janz S., Potter M. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations. Cancer Res. 1995, 55:5012-5018.
264. Robbiani D.F., Bothmer A., Callen E., Reina-San-Martin B., Dorsett Y., Difilippantonio S., Bolland D.J., Chen H.T., Corcoran A.E., Nussenzweig A., Nussenzweig M.C. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008, 135:1028-1038.
265. Chiarle R., Zhang Y., Frock R.L., Lewis S.M., Molinie B., Ho Y.J., Myers D.R., Choi V.W., Compagno M., Malkin D.J., Neuberg D., Monti S., Giallourakis C.C., Gostissa M., Alt F.W. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 2011, 147:107-119.
266. Klein I.A., Resch W., Jankovic M., Oliveira T., Yamane A., Nakahashi H., Di Virgilio M., Bothmer A., Nussenzweig A., Robbiani D.F., Casellas R., Nussenzweig M.C. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 2011, 147:95-106.
267. Rocha P.P., Skok J.A. The origin of recurrent translocations in recombining lymphocytes: a balance between break frequency and nuclear proximity. Curr. Opin. Cell Biol. 2013, 25:365-371.
268. Zhang Y., McCord R.P., Ho Y.J., Lajoie B.R., Hildebrand D.G., Simon A.C., Becker M.S., Alt F.W., Dekker J. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 2012, 148:908-921.
269. Shansab M., Eccleston J.M., Selsing E. Translocation of an antibody transgene requires AID and occurs by interchromosomal switching to all switch regions except the mu switch region. Eur. J. Immunol. 2011, 41:1456-1464.
270. Canning S., Dryja T.P. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:5044-5048.
271. Smanik P.A., Furminger T.L., Mazzaferri E.L., Jhiang S.M. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Hum. Mol. Genet. 1995, 4:2313-2318.
272. Stephens P.J., McBride D.J., Lin M.L., Varela I., Pleasance E.D., Simpson J.T., Stebbings L.A., Leroy C., Edkins S., Mudie L.J., Greenman C.D., Jia M., Latimer C., Teague J.W., Lau K.W., Burton J., Quail M.A., Swerdlow H., Churcher C., Natrajan R., Sieuwerts A.M., Martens J.W., Silver D.P., Langerod A., Russnes H.E., Foekens J.A., Reis-Filho J.S., van't Veer L., Richardson A.L., Borresen-Dale A.L., Campbell P.J., Futreal P.A., Stratton M.R. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462:1005-1010.
273. Nowicki M.O., Falinski R., Koptyra M., Slupianek A., Stoklosa T., Gloc E., Nieborowska-Skorska M., Blasiak J., Skorski T. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004, 104:3746-3753.
274. Sallmyr A., Fan J., Datta K., Kim K.T., Grosu D., Shapiro P., Small D., Rassool F. Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood 2008, 111:3173-3182.
275. Fan J., Li L., Small D., Rassool F. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy. Blood 2010, 116:5298-5305.
276. Li L., Zhang L., Fan J., Greenberg K., Desiderio S., Rassool F.V., Small D. Defective non-homologous end joining blocks B-cell development in FLT3/ITD mice. Blood 2011, 117:3131-3139.
277. Mazzarelli P., Rabitti C., Parrella P., Seripa D., Persichetti P., Marangi G.F., Perrone G., Poeta M.L., Delfino M., Fazio V.M. Differential modulation of Ku70/80 DNA-binding activity in a patient with multiple basal cell carcinomas. J. Invest. Dermatol. 2003, 121:628-633.
278. Pucci S., Mazzarelli P., Rabitti C., Giai M., Gallucci M., Flammia G., Alcini A., Altomare V., Fazio V.M. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 2001, 20:739-747.
279. Bentley J., Diggle C.P., Harnden P., Knowles M.A., Kiltie A.E. DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining. Nucleic Acids Res. 2004, 32:5249-5259.
280. Perrot A., Pionneau C., Azar N., Baillou C., Lemoine F.M., Leblond V., Merle-Beral H., Bene M.C., Herbrecht R., Bahram S., Vallat L. Waldenstrom's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders. Blood Cancer J. 2012, 2:e88.
281. Tobin L.A., Robert C., Nagaria P., Chumsri S., Twaddell W., Ioffe O.B., Greco G.E., Brodie A.H., Tomkinson A.E., Rassool F.V. Targeting abnormal DNA repair in therapy-resistant breast cancers. Mol. Cancer Res. 2011, 10:96-107.
282. Tobin L.A., Robert C., Rapoport A.P., Gojo I., Baer M.R., Tomkinson A.E., Rassool F.V. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene 2013, 32:1784-1793.
283. Srivastava M., Nambiar M., Sharma S., Karki S.S., Goldsmith G., Hegde M., Kumar S., Pandey M., Singh R.K., Ray P., Natarajan R., Kelkar M., De A., Choudhary B., Raghavan S.C. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell 2012, 151:1474-1487.
284. Langerak P., Mejia-Ramirez E., Limbo O., Russell P. Release of Ku and MRN from DNA ends by Mre11 nuclease activity and Ctp1 is required for homologous recombination repair of double-strand breaks. PLoS Genet. 2011, 7:e1002271.
285. Chiruvella K.K., Sebastian R., Sharma S., Karande A.A., Choudhary B., Raghavan S.C. Time-dependent predominance of nonhomologous DNA end-joining pathways during embryonic development in mice. J. Mol. Biol. 2012, 417:197-211.
286. Lieber M.R., Lu H., Gu J., Schwarz K. Flexibility in the order of action and in the enzymology of the nuclease, polymerases, and ligase of vertebrate non-homologous DNA end joining: relevance to cancer, aging, and the immune system. Cell Res. 2008, 18:125-133.
287. van Schendel R., Tijsterman M. Microhomology-mediated intron loss during metazoan evolution. Genome Biol. Evol. 2013, 5:1212-1219.
288. Malyarchuk S., Castore R., Harrison L. DNA repair of clustered lesions in mammalian cells: involvement of non-homologous end-joining. Nucleic Acids Res. 2008, 36:4872-4882.
289. Han J.O., Steen S.B., Roth D.B. Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products. Mol. Cell Biol. 1997, 17:2226-2234.
290. Rooney S., Alt F.W., Lombard D., Whitlow S., Eckersdorff M., Fleming J., Fugmann S., Ferguson D.O., Schatz D.G., Sekiguchi J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J. Exp. Med. 2003, 197:553-565.
291. Zhong Q., Boyer T.G., Chen P.L., Lee W.H. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res. 2002, 62:3966-3970.
292. Bredemeyer A.L., Helmink B.A., Innes C.L., Calderon B., McGinnis L.M., Mahowald G.K., Gapud E.J., Walker L.M., Collins J.B., Weaver B.K., Mandik-Nayak L., Schreiber R.D., Allen P.M., May M.J., Paules R.S., Bassing C.H., Sleckman B.P. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 2008, 456:819-823.
293. Gunn A., Bennardo N., Cheng A., Stark J.M. Correct end use during end joining of multiple chromosomal double-strand breaks is influenced by repair protein RAD50, DNA-dependent protein kinase DNA-PKcs, and transcription context. J. Biol. Chem. 2011, 286:42470-42482.
294. Mansour W.Y., Rhein T., Dahm-Daphi J. The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies. Nucleic Acids Res. 2010, 38:6065-6077.
295. Bindra R.S., Goglia A.G., Jasin M., Powell S.N. Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells. Nucleic Acids Res. 2013, 41:e115.
296. Jiang G., Plo I., Wang T., Rahman M., Cho J.H., Yang E., Lopez B.S., Xia F. BRCA1-Ku80 interaction enhances end-joining fidelity of chromosomal double-strand breaks in G1 phase of the cell cycle. J. Biol. Chem. 2013, 288:8966-8976.
297. Shao L., Feng W., Lee K.J., Chen B.P., Zhou D. A sensitive and quantitative polymerase chain reaction-based cell free in vitro non-homologous end joining assay for hematopoietic stem cells. PLoS ONE 2012, 7:e33499.
298. Helmink B.A., Bredemeyer A.L., Lee B.S., Huang C.Y., Sharma G.G., Walker L.M., Bednarski J.J., Lee W.L., Pandita T.K., Bassing C.H., Sleckman B.P. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J. Exp. Med. 2009, 206:669-679.
299. Weinstock D.M., Jasin M. Alternative pathways for the repair of RAG-induced DNA breaks. Mol. Cell Biol. 2006, 26:131-139.
300. Weinstock D.M., Elliott B., Jasin M. A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 2006, 107:777-780.
301. Jankovic M., Feldhahn N., Oliveira T.Y., Silva I.T., Kieffer-Kwon K.R., Yamane A., Resch W., Klein I., Robbiani D.F., Casellas R., Nussenzweig M.C. 53BP1 alters the landscape of DNA rearrangements and suppresses AID-induced B cell lymphoma. Mol. Cell 2013, 49:623-631.
302. Soutoglou E., Dorn J.F., Sengupta K., Jasin M., Nussenzweig A., Ried T., Danuser G., Misteli T. Positional stability of single double-strand breaks in mammalian cells. Nat. Cell Biol. 2007, 9:675-682.
303. Weinstock D.M., Brunet E., Jasin M. Induction of chromosomal translocations in mouse and human cells using site-specific endonucleases. J. Natl. Cancer Inst. Monogr. 2008, 20-24.
304. Vacchio M.S., Olaru A., Livak F., Hodes R.J. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6323-6328.
305. Bogue M.A., Wang C., Zhu C., Roth D.B. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation,. Immunity 1997, 7:37-47.
306. Eccleston J., Schrader C.E., Yuan K., Stavnezer J., Selsing E. Class switch recombination efficiency and junction microhomology patterns in Msh2-, Mlh1-, and Exo1-deficient mice depend on the presence of mu switch region tandem repeats. J. Immunol. 2009, 183:1222-1228.
307. Manis J.P., Gu Y., Lansford R., Sonoda E., Ferrini R., Davidson L., Rajewsky K., Alt F.W. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J. Exp. Med. 1998, 187:2081-2089.
308. Brunet E., Simsek D., Tomishima M., DeKelver R., Choi V.M., Gregory P., Urnov F., Weinstock D.M., Jasin M. Chromosomal translocations induced at specified loci in human stem cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:10620-10625.
309. Difilippantonio S., Gapud E., Wong N., Huang C.Y., Mahowald G., Chen H.T., Kruhlak M.J., Callen E., Livak F., Nussenzweig M.C., Sleckman B.P., Nussenzweig A. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 2008, 456:529-533.
310. Eccleston J., Yan C., Yuan K., Alt F.W., Selsing E. Mismatch repair proteins MSH2, MLH1, and EXO1 are important for class-switch recombination events occurring in B cells that lack nonhomologous end joining,. J. Immunol. 2011, 186:2336-2343.